MedTrace Logo

Helicobacter Pylori Infection in Renal Transplant Patients

NCT03310255 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2017-10-16

No results posted yet for this study

Summary

Upper gastrointestinal (GI) symptoms are frequent in organ transplant recipients. Peptic ulcers and related pathologies such as gastritis and duodenitis are known to occur with increased frequency (20-60%) and severity in renal transplant recipients. The frequency of severe complications is about 10% among transplant recipients and 10% of those might prove fatal As kidney transplant recipients have to take immunosuppressive drugs for a lifetime and because these drugs have many side effects that may not be differentiated from H. pylori infection Thus, in order to reduce the use of medications and subsequently to reduce the drug interactions ,proper detection and management of H pylori infection in those patients is preferred.

Conditions

  • Helicobacter Pylori Infection
  • Renal Transplant Infection

Interventions

DIAGNOSTIC_TEST

H pylori Faecal Antigen

All patients will be screened for H. pylori using fecal Ag and positive patients will do endoscopy and biopsy.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-12-31
Completion
2019-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310255 on ClinicalTrials.gov